NSAIDs is one of 223 small molecule programs targeting Erectile Dysfunction. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
181 competitors in Rheumatoid Arthritis
NSAIDs
Actos
Celexa
Cataflam
Plaquenil
Voltaren
Vibramycin
Velcade
Vancocin
Pneumococcal Conjugate Vaccine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources